Telehealth Claims Checker
Telehealth companies that sell compounded versions of drugs like Ozempic and Wegovy have been warned by FDA about how they describe them. Paste your copy to see which sentences use the wording FDA quoted, and read every quoted line.
Every warning letter FDA has sent to a telehealth or compounding website about compounded semaglutide and tirzepatide since September 2025, with the exact wording it quoted.
- Warning letters: 108, as of Nov 3, 2026
- Quoted lines: 258
- Sent on Sep 9, 2025, the largest batch: 52
- Quoted a same-ingredient claim: 58%
The copy stays in this browser tab; nothing is sent or stored. No AI model is used: the checks are the patterns described under “How the checker works” below.
What FDA objected to
Letters quoting each kind of wording, of 108, sent mostly in three batches (52 on Sep 9, 2025, 30 on Feb 20, 2026, 25 on Jun 8, 2026). 51 also cited branding that implies the firm is the compounder.
- Same active ingredient as a brand-name drug6358%
- Clinical proof borrowed from the approved drug2624%
- Generic, equivalent, similar to or named for a brand-name drug2119%
- Says the drug or its ingredient is FDA-approved1918%
- Gives a pharmacy or facility an FDA status1413%
- Same results, safety or quality as the brand33%
- Personalized or custom dosing11%
| Wording FDA quoted | Letter | ||
|---|---|---|---|
| Oct 30, 2026 | RonanRx, Inc. dba RonanRx | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Jun 8, 2026 | VivioMD Group LLC dba VivioMD | None of the kinds | FDA letter |
| Jun 8, 2026 | Trinity HealthCare Supply, LLC dba altRx | Clinical proof borrowed from the approved drug | FDA letter |
| Jun 8, 2026 | Thrivelab Co. dba Thrivelab | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Jun 8, 2026 | Roen Health, Inc. dba RoenRx | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Jun 8, 2026 | Ready Med | Same active ingredient as a brand-name drug; Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Public Health Solution LLC dba DrMedHealth | Same active ingredient as a brand-name drug | FDA letter |
| Jun 8, 2026 | OrderlyMeds LLC dba OrderlyMeds | Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Nova Vascular LLC dba NOVARX | Same active ingredient as a brand-name drug; Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Nexus Health Solutions LLC dba Harper Meds | Same active ingredient as a brand-name drug; Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Nexlife Inc. dba Nexlife | None of the kinds | FDA letter |
| Jun 8, 2026 | NativeMed LLC dba NativeMed | Same active ingredient as a brand-name drug | FDA letter |
| Jun 8, 2026 | Momentum Health 360 dba Momentum Health | Same active ingredient as a brand-name drug; Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Medica Weight Loss | Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Clinical proof borrowed from the approved drug | FDA letter |
| Jun 8, 2026 | Maximus Health, Inc. dba Maximus | Gives a pharmacy or facility an FDA status; Clinical proof borrowed from the approved drug | FDA letter |
| Jun 8, 2026 | Joi and Blokes dba Joi + Blokes | Same active ingredient as a brand-name drug | FDA letter |
| Jun 8, 2026 | HydraMed IV LLC dba HydraMed | Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Glow Medispa, LLC dba Mint Med | None of the kinds | FDA letter |
| Jun 8, 2026 | FitRX, LLC dba AM RX | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Jun 8, 2026 | FITISH | Same active ingredient as a brand-name drug | FDA letter |
| Jun 8, 2026 | Ezra Holdco LLC dba Ezra | None of the kinds | FDA letter |
| Jun 8, 2026 | Eden Health International Inc. dba Eden | Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | D&H Medical Services | Same active ingredient as a brand-name drug | FDA letter |
| Jun 8, 2026 | Clover Meds LLC dba Clover Meds | Gives a pharmacy or facility an FDA status | FDA letter |
| Jun 8, 2026 | Amie Health, Inc. dba Amie | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Jun 8, 2026 | Altru Telehealth, LLC dba Altru Telehealth | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Same results, safety or quality as the brand | FDA letter |
| Feb 20, 2026 | Zeuss LLC dba Zeuss | Clinical proof borrowed from the approved drug; Same results, safety or quality as the brand | FDA letter |
| Feb 20, 2026 | Weightless Medical LLC dba WeightCare | None of the kinds | FDA letter |
| Feb 20, 2026 | Viv Health, Inc. dba VIV RX | None of the kinds | FDA letter |
| Feb 20, 2026 | Strut Health, LLC dba Strut | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Feb 20, 2026 | Refills Health, LLC dba Refills Health | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Premium Health Management Inc. dba Premium Health | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Feb 20, 2026 | PharmaZee | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Peaks Curative, LLC dba Peaks | Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Clinical proof borrowed from the approved drug; Same results, safety or quality as the brand | FDA letter |
| Feb 20, 2026 | NewSelf Limited dba NewSelf | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Newman Clinic, PLLC dba Newman Clinic | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | MEDVi, LLC dba MEDVi | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | MaxLife Technologies Inc. dba Maxlife | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Levity Inc. dba Levity | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Lean Rx, Inc. dba SkinnyRx | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Feb 20, 2026 | Kin Meds | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Kare Solutions, LLC dba Zappy | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Join Josie | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Ivim Services LLC dba Ivim | None of the kinds | FDA letter |
| Feb 20, 2026 | Good Girl LLC dba GoodGirlRX | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Genesis Health International Inc. dba Genesis | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | FitRX, LLC dba FitRx | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Dripgym Mobile Parent, LLC dba Amp Health | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | BluefitMD | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Bliv Wellness LLC dba Bliv | None of the kinds | FDA letter |
| Feb 20, 2026 | Better Health Labs, Inc. dba Measured | Same active ingredient as a brand-name drug | FDA letter |
| Feb 20, 2026 | Belle Health LLC dba Belle | None of the kinds | FDA letter |
| Feb 20, 2026 | Aspen Aesthetics dba Fifty 410 | Clinical proof borrowed from the approved drug | FDA letter |
| Feb 20, 2026 | Alan Health Technologies Inc. dba Alan | None of the kinds | FDA letter |
| Feb 20, 2026 | 24HrDoc, Inc. dba 24HrDoc | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | ybycmeds | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Vitals RX | None of the kinds | FDA letter |
| Sep 9, 2025 | Tuyo Health, Inc. dba Tuyo Health | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | TRYM Health, Inc. dba TRYM Health | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Try Nova | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | The HCG Institute | Generic, equivalent, similar to or named for a brand-name drug; Gives a pharmacy or facility an FDA status; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Sprout Health Partners LLC dba Sprout Health | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Slendid | Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | SimpleRx | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | SemaBio | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Reset IV, LLC dba Reset IV | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Remedy Meds | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Nuvo Life Health Inc. dba Nuvo Life Health | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | MedClub by Dr. Jenn | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Matthew Stern, CEO MyStart Health LLC. | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Master Pharmaceuticals Group | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Mane & Steel, LLC. dba Mane & Steel | Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Lumimeds | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Lovely Meds, Inc. dba Lovely Meds | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Lean Dreams LLC dba LeanDreams | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Las Villas Health Care LLC dba Villas Health | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | JulyMD | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | iVisitDoc, Inc. dba iVisitDoc | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Invigorate Med Spa | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Intimate Rose | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | inspire.clinic | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Hims & Hers Health, Inc. dba Hims | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Hims & Hers Health, Inc. dba Hers | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Healthy Male | Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Healthon Inc. dba Healthon | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | HealBerry | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | GLP-1 Solution | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Get.Fit.Medical, LLC dba Get.Fit.Medical | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | GenLabMeds | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Sep 9, 2025 | FWD Care, Inc. dba FWD | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | FitRX, LLC dba Zealthy | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Fancy Meds, LLC dba Fancy Meds | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Personalized or custom dosing | FDA letter |
| Sep 9, 2025 | Expert Aesthetics | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | EvoLife Wellness | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Elite Health Center | Says the drug or its ingredient is FDA-approved | FDA letter |
| Sep 9, 2025 | eDrugstore | Generic, equivalent, similar to or named for a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Sep 9, 2025 | EA WORKS Limited Liability Company dba Trust Labs | Says the drug or its ingredient is FDA-approved | FDA letter |
| Sep 9, 2025 | Dr. Gater’s Weight Loss & Wellness | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | directmeds.com, Inc. dba DirectMeds | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Curex | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | FDA letter |
| Sep 9, 2025 | Cosmo Medical Spa dba Cosmo Med Spa | None of the kinds | FDA letter |
| Sep 9, 2025 | Canada Med Stop | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FDA letter |
| Sep 9, 2025 | Body Good Studio | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | Bioverse, Inc. dba Bioverse | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | ASN-LABS | Same active ingredient as a brand-name drug; Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Sep 9, 2025 | Amazing Meds | Same active ingredient as a brand-name drug | FDA letter |
| Sep 9, 2025 | All American Wellness | Generic, equivalent, similar to or named for a brand-name drug | FDA letter |
| Kind | ||
|---|---|---|
| “Well-Studied Compounded Medications,” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “Compounded medications with substantial human clinical evidence—randomized trials, mechanistic studies, and decades of use—though the specific compounded preparation may not itself be FDA-approved.” | Clinical proof borrowed from the approved drug | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “FDA-Approved Compounded Medications,” | Says the drug or its ingredient is FDA-approved | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “Compounded medications whose active ingredient has at least one FDA-approved branded form for the indication described.” | Says the drug or its ingredient is FDA-approved | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “Explore GLP-1s like Ozempic” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “Yea, seventy-eight dollars a month, for drugs like Ozempic. But are our drugs even legit? No. Our drugs are super [bleep] legit.” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “may not itself be FDA-approved” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “[c]ompounded medications are not FDA-approved” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “American made” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “farm-to-table drugs,” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “farm-to-table drugs” | None of the kinds | RonanRx, Inc. dba RonanRxOct 30, 2026 · FDA letter |
| “GLP-1s are clinically proven medications….” | Clinical proof borrowed from the approved drug | Trinity HealthCare Supply, LLC dba altRxJun 8, 2026 · FDA letter |
| “…clinically proven weight loss.” | Clinical proof borrowed from the approved drug | Trinity HealthCare Supply, LLC dba altRxJun 8, 2026 · FDA letter |
| “Same active ingredient as Ozempic®” | Same active ingredient as a brand-name drug | Thrivelab Co. dba ThrivelabJun 8, 2026 · FDA letter |
| “Same active ingredient as Wegovy and Ozempic” | Same active ingredient as a brand-name drug | Thrivelab Co. dba ThrivelabJun 8, 2026 · FDA letter |
| “clinically proven to work” | Clinical proof borrowed from the approved drug | Thrivelab Co. dba ThrivelabJun 8, 2026 · FDA letter |
| “Semaglutide is the active ingredient in FDA-approved medications like Wegovy and Ozempic….” | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | Roen Health, Inc. dba RoenRxJun 8, 2026 · FDA letter |
| “RoenRx also offers semaglutide, the active ingredient in Wegovy® and Ozempic®….” | Same active ingredient as a brand-name drug | Roen Health, Inc. dba RoenRxJun 8, 2026 · FDA letter |
| “Get affordable semaglutide (main ingredient in Ozempic® & Wegovy®) at an affordable price.” | Same active ingredient as a brand-name drug | Roen Health, Inc. dba RoenRxJun 8, 2026 · FDA letter |
| “Ready Med Medical Weight Loss Center” | None of the kinds | Ready MedJun 8, 2026 · FDA letter |
| “The same active ingredient in Mounjaro® and Zepbound™” | Same active ingredient as a brand-name drug | Ready MedJun 8, 2026 · FDA letter |
| “The same active ingredient in Ozempic® and Rybelsus®” | Same active ingredient as a brand-name drug | Ready MedJun 8, 2026 · FDA letter |
| “FDA licensed compounding facility.” | Gives a pharmacy or facility an FDA status | Ready MedJun 8, 2026 · FDA letter |
| “Same active ingredient as Ozempic®” | Same active ingredient as a brand-name drug | Public Health Solution LLC dba DrMedHealthJun 8, 2026 · FDA letter |
| “Same active ingredient as Mounjaro®” | Same active ingredient as a brand-name drug | Public Health Solution LLC dba DrMedHealthJun 8, 2026 · FDA letter |
| “FDA-licensed pharmacy.” | Gives a pharmacy or facility an FDA status | OrderlyMeds LLC dba OrderlyMedsJun 8, 2026 · FDA letter |
| “…access to the same active ingredient found in Ozempic.” | Same active ingredient as a brand-name drug | Nova Vascular LLC dba NOVARXJun 8, 2026 · FDA letter |
| “FDA Approved Pharmacies.” | Gives a pharmacy or facility an FDA status | Nova Vascular LLC dba NOVARXJun 8, 2026 · FDA letter |
| “Same active ingredient as Ozempic™ & Wegovy™” | Same active ingredient as a brand-name drug | Nexus Health Solutions LLC dba Harper MedsJun 8, 2026 · FDA letter |
| “FDA-licensed 503A Outsourcing Facilities.” | Gives a pharmacy or facility an FDA status | Nexus Health Solutions LLC dba Harper MedsJun 8, 2026 · FDA letter |
| “The same active ingredient in Ozempic® and Wegovy®” | Same active ingredient as a brand-name drug | NativeMed LLC dba NativeMedJun 8, 2026 · FDA letter |
| “Momentum Health” | None of the kinds | Momentum Health 360 dba Momentum HealthJun 8, 2026 · FDA letter |
| “Same active ingredient in Mounjaro® and Zepbound™…” | Same active ingredient as a brand-name drug | Momentum Health 360 dba Momentum HealthJun 8, 2026 · FDA letter |
| “Same active ingredient in Wegovy® and Ozempic®…” | Same active ingredient as a brand-name drug | Momentum Health 360 dba Momentum HealthJun 8, 2026 · FDA letter |
| “Our platform provides seamless access to advanced GLP-1 medications, such as compounded Semaglutide (found in Ozempic® and Wegovy®) and Tirzepatide (found in Mounjaro® and Zepbound™)…” | Same active ingredient as a brand-name drug | Momentum Health 360 dba Momentum HealthJun 8, 2026 · FDA letter |
| “Compounded Semaglutide refers to a medication meticulously formulated [sic] FDA-licensed compounding facility….” | Gives a pharmacy or facility an FDA status | Momentum Health 360 dba Momentum HealthJun 8, 2026 · FDA letter |
| “medica weight loss” | None of the kinds | Medica Weight LossJun 8, 2026 · FDA letter |
| “Clinical studies and FDA approval support [semaglutide’s] safety and effectiveness….” | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | Medica Weight LossJun 8, 2026 · FDA letter |
| “Tirzepatide is FDA-approved….” | Says the drug or its ingredient is FDA-approved | Medica Weight LossJun 8, 2026 · FDA letter |
| “FDA-approved pharmacy.” | Gives a pharmacy or facility an FDA status | Medica Weight LossJun 8, 2026 · FDA letter |
| “Clinically studied ingredients.” | Clinical proof borrowed from the approved drug | Maximus Health, Inc. dba MaximusJun 8, 2026 · FDA letter |
| “Clinically studied to help patients….” | Clinical proof borrowed from the approved drug | Maximus Health, Inc. dba MaximusJun 8, 2026 · FDA letter |
| “Proven to lose weight effectively” | Clinical proof borrowed from the approved drug | Maximus Health, Inc. dba MaximusJun 8, 2026 · FDA letter |
| “FDA approved pharmacies.” | Gives a pharmacy or facility an FDA status | Maximus Health, Inc. dba MaximusJun 8, 2026 · FDA letter |
| “Joi + Blokes” | None of the kinds | Joi and Blokes dba Joi + BlokesJun 8, 2026 · FDA letter |
| “By utilizing the same bioidentical compound as Ozempic and Wegovy, Blokes can provide a cost-effective alternative.” | Same active ingredient as a brand-name drug | Joi and Blokes dba Joi + BlokesJun 8, 2026 · FDA letter |
| “At Blokes, we offer a cost-effective semaglutide option that is bioidentical with more expensive brands.” | Same active ingredient as a brand-name drug | Joi and Blokes dba Joi + BlokesJun 8, 2026 · FDA letter |
| “FDA-approved pharmacy.” | Gives a pharmacy or facility an FDA status | HydraMed IV LLC dba HydraMedJun 8, 2026 · FDA letter |
| “AM Rx also offers semaglutide, the active ingredient in Ozempic® and Wegovy®….” | Same active ingredient as a brand-name drug | FitRX, LLC dba AM RXJun 8, 2026 · FDA letter |
| “Semaglutide is the active ingredient in FDA-approved medications like Wegovy and Ozempic….” | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | FitRX, LLC dba AM RXJun 8, 2026 · FDA letter |
| “Get affordable semaglutide (main ingredient in Ozempic® & Wegovy®) at an affordable price.” | Same active ingredient as a brand-name drug | FitRX, LLC dba AM RXJun 8, 2026 · FDA letter |
| “Semaglutide is the active ingredient in ozempic” | Same active ingredient as a brand-name drug | FITISHJun 8, 2026 · FDA letter |
| “Tirzepatide is the active ingredient in Mounjaro® and Zepbound®” | Same active ingredient as a brand-name drug | FITISHJun 8, 2026 · FDA letter |
| “FDA-licensed 503(a) outsourcing facilities.” | Gives a pharmacy or facility an FDA status | Eden Health International Inc. dba EdenJun 8, 2026 · FDA letter |
| “Same ingredient as Ozempic®” | Same active ingredient as a brand-name drug | D&H Medical ServicesJun 8, 2026 · FDA letter |
| “Same ingredient as Rybelsus®” | Same active ingredient as a brand-name drug | D&H Medical ServicesJun 8, 2026 · FDA letter |
| “Same ingredient as Mounjaro®” | Same active ingredient as a brand-name drug | D&H Medical ServicesJun 8, 2026 · FDA letter |
| “FDA-licensed Facilities.” | Gives a pharmacy or facility an FDA status | Clover Meds LLC dba Clover MedsJun 8, 2026 · FDA letter |
| “Ozempic, Mounjaro, and Wegovy contain the same active ingredients as our compounded versions (semaglutide and tirzepatide).” | Same active ingredient as a brand-name drug | Amie Health, Inc. dba AmieJun 8, 2026 · FDA letter |
| “All our treatments use FDA-approved active ingredients….” | Says the drug or its ingredient is FDA-approved | Amie Health, Inc. dba AmieJun 8, 2026 · FDA letter |
| “Compounded semaglutide combines the FDA approved active ingredient semaglutide with a body safe vitamin such as B12.” | Says the drug or its ingredient is FDA-approved | Altru Telehealth, LLC dba Altru TelehealthJun 8, 2026 · FDA letter |
| “Compounded semaglutide & tirzepatide offers the same results but at a fraction of the cost of brand names such as Ozempic, Mounjaro & Wegovy.” | Same active ingredient as a brand-name drug; Same results, safety or quality as the brand | Altru Telehealth, LLC dba Altru TelehealthJun 8, 2026 · FDA letter |
| “Semaglutide & Tirzepatide is the active ingredient used in FDA-Approved weekly injection Wegovy® and Mounjaro….” | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | Altru Telehealth, LLC dba Altru TelehealthJun 8, 2026 · FDA letter |
| “[o]ur compounding pharmacies are all FDA approved....” | Gives a pharmacy or facility an FDA status | Altru Telehealth, LLC dba Altru TelehealthJun 8, 2026 · FDA letter |
| “GLP-1 is a class of medication that mimic naturally produced hormone in a body. It is FDA approved and clinically proven to work treatment for weight loss.” | Clinical proof borrowed from the approved drug | Zeuss LLC dba ZeussFeb 20, 2026 · FDA letter |
| “Proven Weight Loss” | Clinical proof borrowed from the approved drug | Zeuss LLC dba ZeussFeb 20, 2026 · FDA letter |
| “each batch rigorously tested for efficacy and safety” | Same results, safety or quality as the brand | Zeuss LLC dba ZeussFeb 20, 2026 · FDA letter |
| “Generic Zepbound, Mounjaro” | Generic, equivalent, similar to or named for a brand-name drug | Strut Health, LLC dba StrutFeb 20, 2026 · FDA letter |
| “Semaglutide is the active ingredient in the brand medications.” | Same active ingredient as a brand-name drug | Strut Health, LLC dba StrutFeb 20, 2026 · FDA letter |
| “Tirzepatide is the active ingredient in the brand medications Zepbound® and Mounjaro®.” | Same active ingredient as a brand-name drug | Strut Health, LLC dba StrutFeb 20, 2026 · FDA letter |
| “Refills Health” | None of the kinds | Refills Health, LLC dba Refills HealthFeb 20, 2026 · FDA letter |
| “clinically proven” | Clinical proof borrowed from the approved drug | Refills Health, LLC dba Refills HealthFeb 20, 2026 · FDA letter |
| “the same active ingredient found in certain FDA approved treatments” | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | Refills Health, LLC dba Refills HealthFeb 20, 2026 · FDA letter |
| “Premium Health” | None of the kinds | Premium Health Management Inc. dba Premium HealthFeb 20, 2026 · FDA letter |
| “generic compounded medication” | Generic, equivalent, similar to or named for a brand-name drug | Premium Health Management Inc. dba Premium HealthFeb 20, 2026 · FDA letter |
| “Semaglutide (the active ingredient used in Ozempic® and Wegovy®)” | Same active ingredient as a brand-name drug | Premium Health Management Inc. dba Premium HealthFeb 20, 2026 · FDA letter |
| “Tirzepatide (active ingredient used in Mounjaro®)” | Same active ingredient as a brand-name drug | Premium Health Management Inc. dba Premium HealthFeb 20, 2026 · FDA letter |
| “clinically proven medications” | Clinical proof borrowed from the approved drug | PharmaZeeFeb 20, 2026 · FDA letter |
| “proven prescription medications” | Clinical proof borrowed from the approved drug | PharmaZeeFeb 20, 2026 · FDA letter |
| “Same active ingredient as Ozempic® and Wegovy®” | Same active ingredient as a brand-name drug | PharmaZeeFeb 20, 2026 · FDA letter |
| “This FDA-approved treatment promotes safe, effective weight loss, helping you reduce up to 20% of your body weight and maintain long-term results.” | Says the drug or its ingredient is FDA-approved; Same results, safety or quality as the brand | Peaks Curative, LLC dba PeaksFeb 20, 2026 · FDA letter |
| “Clinically proven to aid in significant weight loss in overweight adults.” | Clinical proof borrowed from the approved drug | Peaks Curative, LLC dba PeaksFeb 20, 2026 · FDA letter |
| “Safe, affordable, and effective.” | Same results, safety or quality as the brand | Peaks Curative, LLC dba PeaksFeb 20, 2026 · FDA letter |
| “The compounded products offered on PeaksCurative.com use FDA approved active pharmaceutical ingredients (API).” | Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status | Peaks Curative, LLC dba PeaksFeb 20, 2026 · FDA letter |
| “Same active ingredient as Ozempic® & Wegovy®” | Same active ingredient as a brand-name drug | NewSelf Limited dba NewSelfFeb 20, 2026 · FDA letter |
| “Same active ingredient as Mounjaro® & Zepbound®” | Same active ingredient as a brand-name drug | NewSelf Limited dba NewSelfFeb 20, 2026 · FDA letter |
| “What is the FDA-approved use of Wegovy?” | None of the kinds | NewSelf Limited dba NewSelfFeb 20, 2026 · FDA letter |
| “What is the FDA-approved use of Zepbound?” | None of the kinds | NewSelf Limited dba NewSelfFeb 20, 2026 · FDA letter |
| “Newman Clinic” | None of the kinds | Newman Clinic, PLLC dba Newman ClinicFeb 20, 2026 · FDA letter |
| “Same Ingredient as Ozempic® and Wegovy®” | Same active ingredient as a brand-name drug | Newman Clinic, PLLC dba Newman ClinicFeb 20, 2026 · FDA letter |
| “Same Ingredient as Mounjaro® and Zepbound®” | Same active ingredient as a brand-name drug | Newman Clinic, PLLC dba Newman ClinicFeb 20, 2026 · FDA letter |
| “Same active ingredient as Wegovy® and Ozempic®.” | Same active ingredient as a brand-name drug | MEDVi, LLC dba MEDViFeb 20, 2026 · FDA letter |
| “Same active ingredient as Mounjaro® and Zepbound®.” | Same active ingredient as a brand-name drug | MEDVi, LLC dba MEDViFeb 20, 2026 · FDA letter |
| “generic compounded medication” | Generic, equivalent, similar to or named for a brand-name drug | MaxLife Technologies Inc. dba MaxlifeFeb 20, 2026 · FDA letter |
| “With the same active ingredient as Wegovy® and Ozempic®, this treatment has been clinically tested and FDA-approved for effective weight management.” | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | MaxLife Technologies Inc. dba MaxlifeFeb 20, 2026 · FDA letter |
| “With the same active ingredient as Mounjaro® and Zepbound®, this treatment has been clinically tested and FDA-approved for effective weight management.” | Same active ingredient as a brand-name drug; Clinical proof borrowed from the approved drug | MaxLife Technologies Inc. dba MaxlifeFeb 20, 2026 · FDA letter |
| “Active ingredients in Ozempic® & Wegovy®” | Same active ingredient as a brand-name drug | MaxLife Technologies Inc. dba MaxlifeFeb 20, 2026 · FDA letter |
| “Active ingredients in Mounjaro® & Zepbound®” | Same active ingredient as a brand-name drug | MaxLife Technologies Inc. dba MaxlifeFeb 20, 2026 · FDA letter |
| “The same ingredient as Ozempic® + Wegovy®” | Same active ingredient as a brand-name drug | Levity Inc. dba LevityFeb 20, 2026 · FDA letter |
| “The power of Saxenda®” | None of the kinds | Levity Inc. dba LevityFeb 20, 2026 · FDA letter |
| “from the same family as GLP-1 treatments like Mounjaro® and Zepbound®” | Same active ingredient as a brand-name drug | Lean Rx, Inc. dba SkinnyRxFeb 20, 2026 · FDA letter |
| “Get access to the same active ingredient as name-brand GLP-1 medications” | Same active ingredient as a brand-name drug | Lean Rx, Inc. dba SkinnyRxFeb 20, 2026 · FDA letter |
| “It contains the same active ingredient as FDA-approved medications” | Same active ingredient as a brand-name drug; Says the drug or its ingredient is FDA-approved | Lean Rx, Inc. dba SkinnyRxFeb 20, 2026 · FDA letter |
| “Same Active Ingredient as common brands” | Same active ingredient as a brand-name drug | Kin MedsFeb 20, 2026 · FDA letter |
| “Hit weight management goals with the same weight loss ingredient as brand-name GLP-1 medications, at a fraction of the cost” | Same active ingredient as a brand-name drug | Kin MedsFeb 20, 2026 · FDA letter |
| “Semaglutide (Active Pharmaceutical Ingredient in Wegovy®)See Wegovy FDA Information” | Same active ingredient as a brand-name drug | Kare Solutions, LLC dba ZappyFeb 20, 2026 · FDA letter |
| “Liraglutide (Active Pharmaceutical Ingredient in Saxenda®)See Saxenda FDA Information” | Same active ingredient as a brand-name drug | Kare Solutions, LLC dba ZappyFeb 20, 2026 · FDA letter |
| “Tirzepatide (Active Pharmaceutical Ingredient in Zepbound®)See Zepbound FDA Information” | Same active ingredient as a brand-name drug | Kare Solutions, LLC dba ZappyFeb 20, 2026 · FDA letter |
| “a proven medication” | Clinical proof borrowed from the approved drug | Kare Solutions, LLC dba ZappyFeb 20, 2026 · FDA letter |
| “Clinically studied and shown to deliver powerful results when combined with healthy habits.” | Clinical proof borrowed from the approved drug | Kare Solutions, LLC dba ZappyFeb 20, 2026 · FDA letter |
| “The same active ingredient found in the FDA-approved brand Wegovy®.” | Same active ingredient as a brand-name drug | Join JosieFeb 20, 2026 · FDA letter |
| “The same active ingredient found in the FDA-approved brand Zepbound®.” | Same active ingredient as a brand-name drug | Join JosieFeb 20, 2026 · FDA letter |
| “FDA-approved meds.” | Says the drug or its ingredient is FDA-approved | Good Girl LLC dba GoodGirlRXFeb 20, 2026 · FDA letter |
| “FDA-approved options” | Says the drug or its ingredient is FDA-approved | Good Girl LLC dba GoodGirlRXFeb 20, 2026 · FDA letter |
| “Clinically proven GLP-1 results” | Clinical proof borrowed from the approved drug | Good Girl LLC dba GoodGirlRXFeb 20, 2026 · FDA letter |
| “Contains the same active ingredient as Ozempic® and Wegovy®” | Same active ingredient as a brand-name drug | Genesis Health International Inc. dba GenesisFeb 20, 2026 · FDA letter |
| “Same active ingredient as Mounjaro®” | Same active ingredient as a brand-name drug | Genesis Health International Inc. dba GenesisFeb 20, 2026 · FDA letter |
| “semaglutide (active ingredient in Wegovy) or tirzepatide (active ingredient in Zepbound)” | Same active ingredient as a brand-name drug | FitRX, LLC dba FitRxFeb 20, 2026 · FDA letter |
| “we can ship semaglutide, the main active ingredient in Wegovy and Ozempic, or Tirzepatide, the main active ingredient in Zepbound and Mounjaro” | Same active ingredient as a brand-name drug | FitRX, LLC dba FitRxFeb 20, 2026 · FDA letter |
| “The same active ingredient in Wegovy®*, Ozempic®*, and Saxenda®*” | Same active ingredient as a brand-name drug | Dripgym Mobile Parent, LLC dba Amp HealthFeb 20, 2026 · FDA letter |
| “Featuring the same active ingredient found in Mounjaro®* and Zepbound®*.” | Same active ingredient as a brand-name drug | Dripgym Mobile Parent, LLC dba Amp HealthFeb 20, 2026 · FDA letter |
| “Deluxe IV and Aesthetics” | None of the kinds | Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFeb 20, 2026 · FDA letter |
| “Same active pharmaceutical ingredient in Ozempic® and Mounjaro®.” | Same active ingredient as a brand-name drug | Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFeb 20, 2026 · FDA letter |
| “Semaglutide is the active pharmaceutical ingredient in Ozempic®*, Rybelsus®*, and Wegovy®*” | Same active ingredient as a brand-name drug | Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFeb 20, 2026 · FDA letter |
| “Tirzepatide is the active pharmaceutical ingredient in Mounjaro®* and Zepbound®*.” | Same active ingredient as a brand-name drug | Deluxe IV Aesthetics PLLC dba Deluxe IV and AestheticsFeb 20, 2026 · FDA letter |
| “Compounded Semaglutide (the same active ingredient as Ozempic® and Wegovy®)” | Same active ingredient as a brand-name drug | BluefitMDFeb 20, 2026 · FDA letter |
| “Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)” | Same active ingredient as a brand-name drug | BluefitMDFeb 20, 2026 · FDA letter |
| “Measured offers compounded GLP-1 treatments made with the same active ingredients found in Wegovy®, Ozempic®, Zepbound®, and Mounjaro®.” | Same active ingredient as a brand-name drug | Better Health Labs, Inc. dba MeasuredFeb 20, 2026 · FDA letter |
| “Same active ingredient in Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Better Health Labs, Inc. dba MeasuredFeb 20, 2026 · FDA letter |
| “Same active ingredient in Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | Better Health Labs, Inc. dba MeasuredFeb 20, 2026 · FDA letter |
| “clinically proven ingredients” | Clinical proof borrowed from the approved drug | Aspen Aesthetics dba Fifty 410Feb 20, 2026 · FDA letter |
| “Same ingredients as: Ozempic and Wegovy” | Same active ingredient as a brand-name drug | 24HrDoc, Inc. dba 24HrDocFeb 20, 2026 · FDA letter |
| “Same ingredients as: Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | 24HrDoc, Inc. dba 24HrDocFeb 20, 2026 · FDA letter |
| “Semaglutide for weight loss - Prefilled Syringes, similar to Ozempic or Wegovy” | Generic, equivalent, similar to or named for a brand-name drug | ybycmedsSep 9, 2025 · FDA letter |
| “Tirzepatide for weight loss - Prefilled Syringes, similar to Mounjaro and Zepbound” | Generic, equivalent, similar to or named for a brand-name drug | ybycmedsSep 9, 2025 · FDA letter |
| “Tirzepatide Peptide 60mg vial - similar to Mounjaro and Zepbound” | Generic, equivalent, similar to or named for a brand-name drug | ybycmedsSep 9, 2025 · FDA letter |
| “Semaglutide Compound 10mg vial - similar to Ozempic or Wegovy” | Generic, equivalent, similar to or named for a brand-name drug | ybycmedsSep 9, 2025 · FDA letter |
| “Vitals RX - Semaglutide/Tirzepatide/Ozempic Weight Loss Clinic” | None of the kinds | Vitals RXSep 9, 2025 · FDA letter |
| “Same active as Wegovy and Ozempic” | Same active ingredient as a brand-name drug | Tuyo Health, Inc. dba Tuyo HealthSep 9, 2025 · FDA letter |
| “Same active ingredient as Zepbound and Mounjaro” | Same active ingredient as a brand-name drug | Tuyo Health, Inc. dba Tuyo HealthSep 9, 2025 · FDA letter |
| “With compounded semaglutide, you get the same trusted active ingredient as in brand-name medications….” | Same active ingredient as a brand-name drug | Tuyo Health, Inc. dba Tuyo HealthSep 9, 2025 · FDA letter |
| “Clinically Proven to Work” | Clinical proof borrowed from the approved drug | TRYM Health, Inc. dba TRYM HealthSep 9, 2025 · FDA letter |
| “Contains the same active ingredient as Mounjaro and ZepBound [sic].” | Same active ingredient as a brand-name drug | TRYM Health, Inc. dba TRYM HealthSep 9, 2025 · FDA letter |
| “Contains the same active ingredient as Ozempic and Wegovy.” | Same active ingredient as a brand-name drug | TRYM Health, Inc. dba TRYM HealthSep 9, 2025 · FDA letter |
| “Same active ingredient as Wegovy & Ozempic.” | Same active ingredient as a brand-name drug | Try NovaSep 9, 2025 · FDA letter |
| “Clinically proven to reduce appetite, lower food cravings, improve food intake regulation and glycemic control.” | Clinical proof borrowed from the approved drug | The HCG InstituteSep 9, 2025 · FDA letter |
| “Compounded Generic Semaglutide is a revolutionary FDA-inspected medication for rapid weight loss that is given once weekly.” | Generic, equivalent, similar to or named for a brand-name drug; Gives a pharmacy or facility an FDA status | The HCG InstituteSep 9, 2025 · FDA letter |
| “All of that said, we recognize that due to American drug marketing, many people only know of semaglutide either as ‘a GLP-1’ or ‘Ozempic’ rather than by the actual name or the preferred brand name. ‘Generic’ or compounded semaglutide, like what we sell here at the HCG Institute, are the same medication, as well.” | Generic, equivalent, similar to or named for a brand-name drug | The HCG InstituteSep 9, 2025 · FDA letter |
| “GLP-1 medications are FDA-approved and backed by extensive clinical research….” | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | Sprout Health Partners LLC dba Sprout HealthSep 9, 2025 · FDA letter |
| “Clinically proven weight loss treatments” | Clinical proof borrowed from the approved drug | SlendidSep 9, 2025 · FDA letter |
| “Semaglutide (Ozempic)” | Generic, equivalent, similar to or named for a brand-name drug | SimpleRxSep 9, 2025 · FDA letter |
| “Tirzepatide (Zepbound)” | Generic, equivalent, similar to or named for a brand-name drug | SimpleRxSep 9, 2025 · FDA letter |
| “Tirzepatide (generic Zepbound)” | Generic, equivalent, similar to or named for a brand-name drug | SimpleRxSep 9, 2025 · FDA letter |
| “generic semaglutide” | Generic, equivalent, similar to or named for a brand-name drug | SemaBioSep 9, 2025 · FDA letter |
| “Semaglutide (the same ingredient in Wegovy & Ozempic)” | Same active ingredient as a brand-name drug | Reset IV, LLC dba Reset IVSep 9, 2025 · FDA letter |
| “Tirzepatide (the same ingredient in Zepbound & Mounjaro)” | Same active ingredient as a brand-name drug | Reset IV, LLC dba Reset IVSep 9, 2025 · FDA letter |
| “Semaglutide (Compounded) Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Remedy MedsSep 9, 2025 · FDA letter |
| “Tirzepatide (Compounded) Same active ingredient as Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | Remedy MedsSep 9, 2025 · FDA letter |
| “Semaglutide Injection (similar to Ozempic and Wegovy)” | Generic, equivalent, similar to or named for a brand-name drug | Nuvo Life Health Inc. dba Nuvo Life HealthSep 9, 2025 · FDA letter |
| “Tirzepatide (similar to Mounjaro)” | Generic, equivalent, similar to or named for a brand-name drug | Nuvo Life Health Inc. dba Nuvo Life HealthSep 9, 2025 · FDA letter |
| “USA Compounded” | None of the kinds | MedClub by Dr. JennSep 9, 2025 · FDA letter |
| “Custom Compounded” | None of the kinds | MedClub by Dr. JennSep 9, 2025 · FDA letter |
| “Generic Ozempic” | Generic, equivalent, similar to or named for a brand-name drug | MedClub by Dr. JennSep 9, 2025 · FDA letter |
| “Generic Ozempic” | Generic, equivalent, similar to or named for a brand-name drug | Matthew Stern, CEO MyStart Health LLC.Sep 9, 2025 · FDA letter |
| “Save with generics that offer the same active ingredients and results.” | Same active ingredient as a brand-name drug | Matthew Stern, CEO MyStart Health LLC.Sep 9, 2025 · FDA letter |
| “Semaglutide (Ozempic/Wegovy)” | Generic, equivalent, similar to or named for a brand-name drug | Master Pharmaceuticals GroupSep 9, 2025 · FDA letter |
| “Tirzepatide (Mounjaro/Zepbound)” | Generic, equivalent, similar to or named for a brand-name drug | Master Pharmaceuticals GroupSep 9, 2025 · FDA letter |
| “Clinically Proven Weight Loss” | Clinical proof borrowed from the approved drug | Mane & Steel, LLC. dba Mane & SteelSep 9, 2025 · FDA letter |
| “Clinically proven GLP-1 therapy to suppress appetite, regulate blood sugar, and accelerate fat loss—trusted by medical professionals worldwide.” | Clinical proof borrowed from the approved drug | Mane & Steel, LLC. dba Mane & SteelSep 9, 2025 · FDA letter |
| “Doctors frequently recommend Compounded Tirzepatide or Compounded Semaglutide, both of which are GLP-1 agonists with the same active ingredient as the brand name medications.” | Same active ingredient as a brand-name drug | LumimedsSep 9, 2025 · FDA letter |
| “GLP-1 Injections contain GLP-1, which mimics a naturally occurring hormone in the body. This is the same active ingredient used in brand name GLP-1 weight-loss medications. GLP-1 was FDA-approved in 2017 . . . . It was FDA-approved in 2021 for weight loss.” | Same active ingredient as a brand-name drug | LumimedsSep 9, 2025 · FDA letter |
| “Same active ingredient as Wegovy and Ozempic” | Same active ingredient as a brand-name drug | Lovely Meds, Inc. dba Lovely MedsSep 9, 2025 · FDA letter |
| “Same active ingredient as Zepbound & Mounjaro” | Same active ingredient as a brand-name drug | Lovely Meds, Inc. dba Lovely MedsSep 9, 2025 · FDA letter |
| “Compounded Semaglutide has the same active ingredient as Ozempic and Wegovy.” | Same active ingredient as a brand-name drug | Lean Dreams LLC dba LeanDreamsSep 9, 2025 · FDA letter |
| “With compounded Tirzepatide, you get the same active ingredient found in Mounjaro and Zepbound.” | Same active ingredient as a brand-name drug | Lean Dreams LLC dba LeanDreamsSep 9, 2025 · FDA letter |
| “Semaglutide GLP-1 is a once-a-week injection that contains the same active ingredient as Ozempic and Wegovy….” | Same active ingredient as a brand-name drug | Las Villas Health Care LLC dba Villas HealthSep 9, 2025 · FDA letter |
| “Sildenafil 2%: the active ingredient in Viagra. Clinically proven to improve outcomes in women with sexual arousal disorder by increasing blood flow to the genitals.” | Clinical proof borrowed from the approved drug | Las Villas Health Care LLC dba Villas HealthSep 9, 2025 · FDA letter |
| “Our Semaglutide injection, featuring the same active ingredient as Wegovy and Ozempic, offers a powerful solution.” | Same active ingredient as a brand-name drug | JulyMDSep 9, 2025 · FDA letter |
| “Yes, Semaglutide is the active ingredient in Ozempic and Wegovy, a medication commonly used to manage type 2 diabetes and support weight loss. If you’re looking for an affordable alternative, consider trying our compounded Semaglutide. It offers the same effective ingredient as Ozempic and Wegovy, but at a fraction of the price.” | Same active ingredient as a brand-name drug | JulyMDSep 9, 2025 · FDA letter |
| “Compounded semaglutide from iVisitDoc has the same active ingredients as Wegovy and Ozempic, but doesn’t come in a preloaded pen.” | Same active ingredient as a brand-name drug | iVisitDoc, Inc. dba iVisitDocSep 9, 2025 · FDA letter |
| “Clinically Validated Ingredients” | Clinical proof borrowed from the approved drug | iVisitDoc, Inc. dba iVisitDocSep 9, 2025 · FDA letter |
| “Semaglutide (Wegovy)” | Generic, equivalent, similar to or named for a brand-name drug | Invigorate Med SpaSep 9, 2025 · FDA letter |
| “Tirzepatide/B12 (Mounjaro)” | Generic, equivalent, similar to or named for a brand-name drug | Invigorate Med SpaSep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Intimate RoseSep 9, 2025 · FDA letter |
| “Same active ingredient as Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | Intimate RoseSep 9, 2025 · FDA letter |
| “Semaglutide (similar to Ozempic) 2.5 mg vial” | Generic, equivalent, similar to or named for a brand-name drug | inspire.clinicSep 9, 2025 · FDA letter |
| “Tirzepatide (similar to Mounjaro) 10 mg vial” | Generic, equivalent, similar to or named for a brand-name drug | inspire.clinicSep 9, 2025 · FDA letter |
| “5 mg of semaglutide comparable to Ozempic. [sic]” | Generic, equivalent, similar to or named for a brand-name drug | inspire.clinicSep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Hims & Hers Health, Inc. dba HimsSep 9, 2025 · FDA letter |
| “Clinically proven ingredients” | Clinical proof borrowed from the approved drug | Hims & Hers Health, Inc. dba HimsSep 9, 2025 · FDA letter |
| “Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Hims & Hers Health, Inc. dba HersSep 9, 2025 · FDA letter |
| “Clinically proven ingredients” | Clinical proof borrowed from the approved drug | Hims & Hers Health, Inc. dba HersSep 9, 2025 · FDA letter |
| “Clinically shown to support 15-22% average body weight reduction.” | Clinical proof borrowed from the approved drug | Healthy MaleSep 9, 2025 · FDA letter |
| “Clinically proven medications and compounds for sustainable weight management” | Clinical proof borrowed from the approved drug | Healthy MaleSep 9, 2025 · FDA letter |
| “Clinically proven to deliver sustainable results….” | Clinical proof borrowed from the approved drug | Healthy MaleSep 9, 2025 · FDA letter |
| “Same active ingredient as Wegovy and Ozempic.” | Same active ingredient as a brand-name drug | Healthon Inc. dba HealthonSep 9, 2025 · FDA letter |
| “Same active ingredient as Mounjaro pens and Zepbound.” | Same active ingredient as a brand-name drug | Healthon Inc. dba HealthonSep 9, 2025 · FDA letter |
| “Clinically proven weight loss” | Clinical proof borrowed from the approved drug | Healthon Inc. dba HealthonSep 9, 2025 · FDA letter |
| “The active ingredient in our formula is FDA-approved….” | Says the drug or its ingredient is FDA-approved | Healthon Inc. dba HealthonSep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | HealBerrySep 9, 2025 · FDA letter |
| “Semaglutide is the generic drug delivered in Ozempic (injectable) and Rybelsus (oral) diabetes control medications, and Wegovy (injectable) weight loss medication.” | Generic, equivalent, similar to or named for a brand-name drug | GLP-1 SolutionSep 9, 2025 · FDA letter |
| “SILDENAFIL (GENERIC VIAGRA)” | Generic, equivalent, similar to or named for a brand-name drug | Get.Fit.Medical, LLC dba Get.Fit.MedicalSep 9, 2025 · FDA letter |
| “TADALAFIL (GENERIC CIALIS)” | Generic, equivalent, similar to or named for a brand-name drug | Get.Fit.Medical, LLC dba Get.Fit.MedicalSep 9, 2025 · FDA letter |
| “SEMAGLUTIDE (GENERIC OZEMPIC/WEGOVY)” | Generic, equivalent, similar to or named for a brand-name drug | Get.Fit.Medical, LLC dba Get.Fit.MedicalSep 9, 2025 · FDA letter |
| “TIRZEPATIDE (GENERIC MOUNJARO)” | Generic, equivalent, similar to or named for a brand-name drug | Get.Fit.Medical, LLC dba Get.Fit.MedicalSep 9, 2025 · FDA letter |
| “Compounded Retatrutide [--] Active Ingredient in Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | GenLabMedsSep 9, 2025 · FDA letter |
| “Compounded Retatrutide [--] Active Ingredient in Ozempic and Wegovy” | Same active ingredient as a brand-name drug | GenLabMedsSep 9, 2025 · FDA letter |
| “What does the treatment plan generally look like? The standard, FDA-approved dosing schedule for Retatrutide is: Month 1: 0.25 mg per week…” | Says the drug or its ingredient is FDA-approved | GenLabMedsSep 9, 2025 · FDA letter |
| “Doctors frequently recommend Compounded Tirzepatide (Mounjaro/Zepbound) or Compounded Semaglutide (Wegovy, Ozempic), which are both GLP-1 agonists.” | Generic, equivalent, similar to or named for a brand-name drug | GenLabMedsSep 9, 2025 · FDA letter |
| “Manage weight affordably with compounded GLP-1, the same active ingredients as Wegovy, Ozempic, Zepbound & Mounjaro” | Same active ingredient as a brand-name drug | FWD Care, Inc. dba FWDSep 9, 2025 · FDA letter |
| “Same active ingredient in Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | FWD Care, Inc. dba FWDSep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | FWD Care, Inc. dba FWDSep 9, 2025 · FDA letter |
| “Is Semaglutide the same as Wegovy and Ozempic? Semaglutide is the active ingredient in Wegovy and Ozempic. Semaglutide is often more cost effective...” | Same active ingredient as a brand-name drug | FitRX, LLC dba ZealthySep 9, 2025 · FDA letter |
| “Your healthcare provider will help you find the right dose of GLP-1 Medication including Semaglutide (same active ingredient as Wegovy, and Ozempic), to achieve healthy weight loss.” | Same active ingredient as a brand-name drug | FitRX, LLC dba ZealthySep 9, 2025 · FDA letter |
| “Semaglutide is the active ingredient in Wegovy and Ozempic. Semaglutide is often more cost effective for Zealthy members whose insurance deny coverage of brand name medication like Wegovy or who are uninsured.” | Same active ingredient as a brand-name drug | FitRX, LLC dba ZealthySep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “Same active ingredient as Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “Compounding semaglutide involves creating small, customized batches of the medication in an FDA-monitored, state-licensed pharmacy, using FDA-approved ingredients….” | Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Personalized or custom dosing | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “Compounding tirzepatide involves creating small, customized batches of the medication in an FDA-monitored, state-licensed pharmacy, using FDA-approved ingredients….” | Says the drug or its ingredient is FDA-approved; Gives a pharmacy or facility an FDA status; Personalized or custom dosing | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “Though they contain the same active ingredient as branded Mounjaro and Zepbound, compounded versions are much more affordable, so you win!” | Same active ingredient as a brand-name drug | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “Though they contain the same active ingredient as branded Ozempic and Wegovy, compounded versions are much more affordable, so you win!” | Same active ingredient as a brand-name drug | Fancy Meds, LLC dba Fancy MedsSep 9, 2025 · FDA letter |
| “At home weight loss with the popular Ozempic generic Semaglutide.” | Generic, equivalent, similar to or named for a brand-name drug | Expert AestheticsSep 9, 2025 · FDA letter |
| “At home weight loss with the popular Mounjaro generic Tirzepatide.” | Generic, equivalent, similar to or named for a brand-name drug | Expert AestheticsSep 9, 2025 · FDA letter |
| “Clinically Proven: Semaglutide is FDA-approved for chronic weight management….” | Says the drug or its ingredient is FDA-approved; Clinical proof borrowed from the approved drug | EvoLife WellnessSep 9, 2025 · FDA letter |
| “Compounded semaglutide was first introduced and patented in 2016, and FDA approved as a type 2 diabetes treatment in 2017. It wasn’t until 2021 that compounded semaglutide was approved as a treatment for obesity!” | Says the drug or its ingredient is FDA-approved | Elite Health CenterSep 9, 2025 · FDA letter |
| “FDA-Approved Active” | Says the drug or its ingredient is FDA-approved | eDrugstoreSep 9, 2025 · FDA letter |
| “eDrugstore guarantees that all Tirzepatide medications are genuine, FDA-approved formulations for maximum efficacy and safety.” | Says the drug or its ingredient is FDA-approved | eDrugstoreSep 9, 2025 · FDA letter |
| “Tirzepatide (Zepbound)….” | Generic, equivalent, similar to or named for a brand-name drug | eDrugstoreSep 9, 2025 · FDA letter |
| “FDA approval: Semaglutide was approved by the U.S. Food and Drug Administration (FDA) in December 2017.” | Says the drug or its ingredient is FDA-approved | EA WORKS Limited Liability Company dba Trust LabsSep 9, 2025 · FDA letter |
| “FDA approval: Tirzepatide was approved by the U.S. Food and Drug Administration (FDA) in 2022.” | Says the drug or its ingredient is FDA-approved | EA WORKS Limited Liability Company dba Trust LabsSep 9, 2025 · FDA letter |
| “Tirzepatide is the active ingredient in Mounjaro….” | Same active ingredient as a brand-name drug | Dr. Gater’s Weight Loss & WellnessSep 9, 2025 · FDA letter |
| “Semaglutide,[ sic ] is the generic version of Ozempic/Wegovy. The generic version Semiglutide [ sic ] allows for affordability and accessibility to everyday consumers looking to attain a healthy weight.” | Generic, equivalent, similar to or named for a brand-name drug | Dr. Gater’s Weight Loss & WellnessSep 9, 2025 · FDA letter |
| “While the Brand Ozempic from retail pharmacies is extremely expensive, Dr. Gater has licensed pharmacies that can dispense Brand Ozempic at a much more affordable price. You can purchase Brand Ozempic through our website at a significant cost savings. All prescription medications including generic Semiglutide [ sic ] and brand Ozempic require a telemedicine visit with a medical provider prior [ sic ] a prescription being sent to our partner pharmacies.” | Generic, equivalent, similar to or named for a brand-name drug | Dr. Gater’s Weight Loss & WellnessSep 9, 2025 · FDA letter |
| “Compounded Semiglutide [ sic ] is the generic equivalent of the brand names and pharmacologically similar to Ozempic & Wegovy.” | Generic, equivalent, similar to or named for a brand-name drug | Dr. Gater’s Weight Loss & WellnessSep 9, 2025 · FDA letter |
| “Generic Ozempic” | Generic, equivalent, similar to or named for a brand-name drug | Dr. Gater’s Weight Loss & WellnessSep 9, 2025 · FDA letter |
| “If you’ve looked into brand-name versions of semaglutide, you know the cost can be steep – especially without insurance. That’s where buying compounded semaglutide online can make a big difference. Compounded medications are created by licensed compounding pharmacies using the same active ingredients.” | Same active ingredient as a brand-name drug | directmeds.com, Inc. dba DirectMedsSep 9, 2025 · FDA letter |
| “Compounded semaglutide contains the same active ingredient as branded semaglutide.” | Same active ingredient as a brand-name drug | directmeds.com, Inc. dba DirectMedsSep 9, 2025 · FDA letter |
| “Don’t give up hope if brand-name Mounjaro is out of reach due to cost. You may be able to get compounded tirzepatide online, which is an effective and budget-friendly alternative. Compounded formulations use the same active ingredient as the brand-name drug, customized by licensed compounding pharmacies to meet your needs.” | Same active ingredient as a brand-name drug | directmeds.com, Inc. dba DirectMedsSep 9, 2025 · FDA letter |
| “Clinically proven success” | Clinical proof borrowed from the approved drug | CurexSep 9, 2025 · FDA letter |
| “Clinically proven weight loss treatments” | Clinical proof borrowed from the approved drug | CurexSep 9, 2025 · FDA letter |
| “The same active ingredients as Ozempic or Mounjaro” | Same active ingredient as a brand-name drug | CurexSep 9, 2025 · FDA letter |
| “Prescription weight loss with the same active ingredients as Mounjaro & Zepbound.” | Same active ingredient as a brand-name drug | CurexSep 9, 2025 · FDA letter |
| “While we don’t prescribe Ozempic, Wegovy, Zepbound, or Mounjaro directly, we may prescribe treatments containing the same active ingredients.” | Same active ingredient as a brand-name drug | CurexSep 9, 2025 · FDA letter |
| “Ozempic (semaglutide) injection (4 weeks supply)” | None of the kinds | Cosmo Medical Spa dba Cosmo Med SpaSep 9, 2025 · FDA letter |
| “Ozempic (semaglutide) injection (10 weeks supply)” | None of the kinds | Cosmo Medical Spa dba Cosmo Med SpaSep 9, 2025 · FDA letter |
| “The same active ingredient in branded weight loss medications.” | Same active ingredient as a brand-name drug | Canada Med StopSep 9, 2025 · FDA letter |
| “FDA-Approved Medication” | Says the drug or its ingredient is FDA-approved | Canada Med StopSep 9, 2025 · FDA letter |
| “Compound semaglutide is made of the same active ingredients as Ozempic and Wegovy, which are GLP-1 receptor agonist [sic]….” | Same active ingredient as a brand-name drug | Body Good StudioSep 9, 2025 · FDA letter |
| “Same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Bioverse, Inc. dba BioverseSep 9, 2025 · FDA letter |
| “The same active ingredient in Mounjaro and Zepbound” | Same active ingredient as a brand-name drug | Bioverse, Inc. dba BioverseSep 9, 2025 · FDA letter |
| “Semaglutide, the same active ingredient in Ozempic and Wegovy, is a GLP-1 RA recognized for effective weight loss.” | Same active ingredient as a brand-name drug | Bioverse, Inc. dba BioverseSep 9, 2025 · FDA letter |
| “Doctor-trusted ingredients, formulated with the same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Bioverse, Inc. dba BioverseSep 9, 2025 · FDA letter |
| “Weight loss specialists frequently prescribe compounded semaglutide, which contains the same active ingredient as Ozempic and Wegovy” | Same active ingredient as a brand-name drug | Bioverse, Inc. dba BioverseSep 9, 2025 · FDA letter |
| “The same active ingredient as Wegovy and Ozempic” | Same active ingredient as a brand-name drug | ASN-LABSSep 9, 2025 · FDA letter |
| “Semaglutide is the generic drug in Ozempic (injectable) and Rybelsus (oral) diabetes control medications, and Wegovy (injectable) weight loss medication.” | Generic, equivalent, similar to or named for a brand-name drug | ASN-LABSSep 9, 2025 · FDA letter |
| “Compounded semaglutide (same as Ozempic/Wegovy)” | Same active ingredient as a brand-name drug | Amazing MedsSep 9, 2025 · FDA letter |
| “Mounjaro’s compounded version- Tirzepatide Prescription” | Generic, equivalent, similar to or named for a brand-name drug | All American WellnessSep 9, 2025 · FDA letter |
| “Ozempic’s compounded version- Semaglutide” | Generic, equivalent, similar to or named for a brand-name drug | All American WellnessSep 9, 2025 · FDA letter |
Letters are CDER warning letters, read from FDA's pages. They state FDA's allegations and are not court findings. The kinds of wording are labels this tool adds with fixed patterns, and every line links to FDA's own letter. FDA warning letters · Updated Nov 3, 2026
About the telehealth claims checker
What FDA said about each kind of wording
- Same active ingredient as a brand-name drug. FDA says this implies the compounded drug is the same as an FDA-approved drug, or has been evaluated like one. Compounded drugs are not FDA-approved.
- Generic, equivalent, similar to or named for a brand-name drug. FDA says a compounded drug is not a generic. Generic drugs are approved before they are marketed. Compounded drugs are not.
- Says the drug or its ingredient is FDA-approved. FDA says compounded drugs are not FDA-approved and the agency does not review them for safety, effectiveness or quality before they are marketed.
- Gives a pharmacy or facility an FDA status. FDA says it does not approve or license compounding pharmacies or outsourcing facilities. Calling one FDA-approved, licensed, registered or inspected implies a status FDA does not grant.
- Clinical proof borrowed from the approved drug. FDA says a compounded drug has not been shown in clinical trials to give the results of the approved drug, and claiming it has is misleading.
- Same results, safety or quality as the brand. FDA says the same-results and same-quality claims are not supported for a compounded drug, which FDA has not reviewed for safety, effectiveness or quality.
- Personalized or custom dosing. FDA says a personalized-dosing claim is unsupported unless the prescriber has a documented clinical need for a change to the approved drug.
The laws the letters cite are sections 502(a) and 502(bb) of the FD&C Act: a drug is misbranded if its labeling is false or misleading, and a compounded drug is misbranded if its advertising or promotion is. FDA's plain-language summary is on its page FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs.
How the checker works
The page splits your copy into sentences and bullets. Each is tested against a short list of patterns for every kind of wording, such as “same active ingredient as” a brand name, “generic”, “FDA-approved pharmacy” and “clinically proven”. A sentence that matches is shown with the closest line FDA quoted for that kind, ranked by shared words. “Nearly this wording” means at least 80% of the shorter line's words appear in the other.
The same patterns sorted the lines FDA quoted, so the checker finds what these letters contain. It will miss a new way of saying the same thing, and it reads words only.
Which letters are included
CDER warning letters dated 9 September 2025 or later whose text says FDA reviewed the firm's website and names compounded semaglutide, tirzepatide, liraglutide or retatrutide. Quoted lines are the passages FDA put in quotation marks before the paragraph asking for a response. Statute names and trademark lists are dropped. 24 of 258 lines, mostly business names and headings, fit none of the kinds and are shown as “None of the kinds”.
Frequently asked questions
- Does a flag mean FDA would send a warning letter?
- No. A flag means a sentence reads like wording FDA quoted in a letter. FDA writes to a firm after reviewing its whole site, and it can object to things this checker cannot see: images, prices, how a pharmacy is described, and what the product label says. A warning letter states FDA's allegation. It is not a finding that a court has made.
- Is my copy uploaded?
- No. The checker runs in your browser tab. The copy you paste is never sent or stored.
- Does it use an AI model?
- No. Each sentence is tested with a short list of patterns, the same ones used to sort the 258 lines FDA quoted. A test fails if the page and the data build ever disagree on how a quoted line is sorted. Because the patterns were written from these letters, they find wording like what FDA quoted and miss new phrasings.
- Why does my sentence about the brand not get flagged?
- A sentence that says compounded drugs are not FDA-approved, or are not the same as a brand-name drug, is skipped. So is wording that names none of the categories. Naming a brand-name drug in a sentence is not itself flagged.
- How many letters are there, and why do other counts differ?
- 108 letters in this set, dated Sep 9, 2025 to Oct 30, 2026. We include a CDER warning letter when its text says FDA reviewed the firm's website and it names compounded semaglutide, tirzepatide, liraglutide or retatrutide. Other trackers count 110 to 113 because they include or leave out different letters, for example letters to bulk-ingredient sellers.
- Where is the data, and can I reuse it?
- The lines and letters are public as JSON at arca.inc/data/telehealth-claims.json and as spreadsheets at arca.inc/data/telehealth-claims.csv (one row per quoted line) and arca.inc/data/telehealth-letters.csv (one row per letter). The text of each letter belongs to FDA and is linked from every row.
Review every claim before it runs
Arca's MLR and promotional review playbook takes each claim in a promotional piece, checks it against your approved sources, past campaigns and the FDA letters on file, and routes findings to medical, legal and regulatory reviewers with the source cited. See Arca for MLR review.